Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-07-25
1999-10-12
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 530399, A61K 3822, C07K 14575
Patent
active
059655208
ABSTRACT:
Disclosed is a therapeutic regime for treating patients with rheumatoid arthritis (RA) Supplemental growth hormone is periodically administered to raise insulin-like growth factor 1 (IGF-1) levels, and the IGF-1 levels are monitored until they reach optimal levels and RA symptoms subside.
REFERENCES:
patent: 5378686 (1995-01-01), Bennett
File Caplus on STN. No. 1969:488134. Ingvasson, C. G. `Prolactin in Rheumatoid arthritis. Therapeutic Test`, Acta Rheumatol. Scand. vol. 15, No. 1, pp. 4-17 (abstract only), 1969).
Bennett, Robert M., "Beyond Fibromyaglia: Ideas on Etiology and Treatment," J. Rheumatology 1989 (Supplement 19) vol. 16, pp. 185-191.
Bennett, Robert M., et al., "Low Levels of Somatomedin C in Patients with the Fibromyaglia Syndrome," Arth. & Rheum., vol. 35, No. 10, pp. 1113-1116 (Oct. 1992).
Haapasaari et al., ;Growth Hormone Treatment in Children with Ubnenile Rheumatoid Arthritis', Scandinavian Journal of Rheumatology, Supplement 45, p. 40, Jun. 1982.
Gupna Anish
Research Corporation Technologies
Tsang Cecilia J.
LandOfFree
Therapeutic treatment of rheumatoid arthritis and polymyalgia rh does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic treatment of rheumatoid arthritis and polymyalgia rh, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic treatment of rheumatoid arthritis and polymyalgia rh will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-652338